tiprankstipranks
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX

Compare Insight Molecular Diagnostics (IMDX) vs. Competitors

430 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Insight Molecular Diagnostics
$3.18
$102.29M
-4.55
7.80%
2 Buy
1 Hold
0 Sell
Moderate Buy
Atossa Therapeutics
$4.98
$42.88M
-2.19
-46.46%
3 Buy
0 Hold
0 Sell
Strong Buy
MacroGenics
$3.44
$218.63M
-1.36
170.87%
2 Buy
2 Hold
0 Sell
Moderate Buy
Elutia
$0.64
$48.35M
0.54
-54.62%
1 Buy
0 Hold
0 Sell
Moderate Buy
Surrozen
$27.45
$315.31M
-0.23
190.48%
4 Buy
0 Hold
0 Sell
Strong Buy
Telomir Pharmaceuticals, Inc.
$1.35
$43.32M
-4.04
-56.40%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMDX
Insight Molecular Diagnostics
3.18
0.40
14.39%
ATOS
Atossa Therapeutics
4.98
-4.71
-48.61%
MGNX
MacroGenics
3.44
2.15
166.67%
ELUT
Elutia
1.13
-1.04
-47.93%
SRZN
Surrozen
27.45
18.45
205.00%
TELO
Telomir Pharmaceuticals, Inc.
1.26
-1.43
-53.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts